Medicine Description
Indication For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer. Pharmacodynamics Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers. Mechanism of action Nizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.
|
the price nizatine 150mg Capsule in saudi arabia |
24.24 SAR | SAR |
|
the price nizatine 150mg Capsule in uae |
24.24 AED | AED |
|
the price nizatine 150mg Capsule in kuwait |
1.98 KWD | KWD |
|
the price nizatine 150mg Capsule in oman |
2.42 OMR | OMR |
|
the price nizatine 150mg Capsule in Bahrain |
2.42 BHD | BHD |